The booming illicit peptide market could already be worth an estimated $3 billion. And with an FDA panel expected to give its stamp of approval to as many as seven new drugs, companies are preparing for a windfall.

Injectable peptides, a broad category of amino acid-based drugs, have grown in popularity for their purported healing and anti-inflammatory properties, but there’s little scientific data on their safety and efficacy. The FDA is expected to recommend legal production of this group of peptides, which Health and Human Services Secretary Robert F. Kennedy Jr. also happens to be a fan of.

Compounding pharmacies like Empower and telehealth giant Hims & Hers are waiting for the FDA’s green light to unlock a potential multibillion-dollar market.

This is a published version of the Forbes Daily newsletter, you can sign-up to get Forbes Daily in your inbox here.

OpenAI admitted that its AI systems went rogue and hacked the servers of AI platform Hugging Face, which used a Chinese AI model to to fight the cyberattack.

Iran appeared to seize a tanker owned by Greek shipping magnate George Prokopiou in the Strait of Hormuz, as commercial traffic through the crucial shipping route has once again been effectively halted.

Paramount Skydance’s $110 billion takeover of Warner Bros. Discovery cleared a major regulatory hurdle with approval from the European Union, though the deal still faces antitrust concerns in the U.S.

Google parent Alphabet surpassed Wall Street’s earnings projections with its 12th-straight quarter of double-digit revenue growth. The company’s AI assistant Gemini now has 950 million monthly active users, CEO Sundar Pichai said in a statement, and Google Cloud revenue surged 82%.

Elon Musk said there’s “more and more overlap” between SpaceX and Tesla, but deflected questions about a direct........

© Forbes